The 5α-reductase type 1 isozyme is a key enzyme in the metabolism of the androgen steroid hormones and inhibitors of this enzyme represent a new pharmacological treatment for several androgen dependent diseases. We developed a radiosubstrate in vitro incubation method for the determination of 5α-reductase type 1 activity using rat liver microsomes as an enzyme source. With this method we have studied the inhibiting activity of novel (5′ S )-17β-(4,5-dihydrooxazol-5-yl)androst-5-en-3-one compounds containing various derivatized phenyl substituents coupled to the exo -heterocyclic moiety. Tests revealed moderate inhibitory actions compared to finasteride, nevertheless, results provide interesting structure-activity relationship data.
Andersson, S., Russell, D. W. (1990) Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc. Natl. Acad. Sci. USA 87 , 3640–3644.
Russell D. W. , 'Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases ' (1990 ) 87 Proc. Natl. Acad. Sci. USA : 3640 -3644 .
Bhattacharyya, A. K., Wang, M., Rajagopalan, K., Taylor, M. F., Hiipakka, R., Liao, S., Collins, D. C. (1999) Analysis of the steroid binding domain of rat steroid 5α-reductase (isozyme-1): the steroid D-ring binding domain of 5α-reductase. Steroids 64 , 197–204.
Collins D. C. , 'Analysis of the steroid binding domain of rat steroid 5α-reductase (isozyme-1): the steroid D-ring binding domain of 5α-reductase ' (1999 ) 64 Steroids : 197 -204 .
Chen, W., Thiboutot, D., Zouboulis, C. C. (2002) Cutaneous androgen metabolism: basic research and clinical perspectives. J. Invest. Dermatol. 119 , 992–1007.
Zouboulis C. C. , 'Cutaneous androgen metabolism: basic research and clinical perspectives ' (2002 ) 119 J. Invest. Dermatol. : 992 -1007 .
Farkash, Y., Soreq, H., Orly, J. (1988) Biosynthesis of catalytically active rat testosterone 5α-reductase in microinjected Xenopus oocytes: evidence for tissue-specific differences in translatable mRNA. Proc. Natl. Acad. Sci. USA 85 , 5824–5828.
Orly J. , 'Biosynthesis of catalytically active rat testosterone 5α-reductase in microinjected Xenopus oocytes: evidence for tissue-specific differences in translatable mRNA ' (1988 ) 85 Proc. Natl. Acad. Sci. USA : 5824 -5828 .
Gerst, C., Dalko, M., Pichaud, P., Galey, J. B., Buan, B., Bernard, B. A. (2002) Type-1 steroid 5α-reductase is functionally active in the hair follicle as evidenced by new selective inhibitors of either type-1 or type-2 human steroid 5α-reductase. Exp. Dermatol. 11 , 52–58.
Bernard B. A. , 'Type-1 steroid 5α-reductase is functionally active in the hair follicle as evidenced by new selective inhibitors of either type-1 or type-2 human steroid 5α-reductase ' (2002 ) 11 Exp. Dermatol. : 52 -58 .
Harris, G., Azzolina, B., Baginsky, W., Cimis, G., Rasmusson, G. H., Tolman, R. L., Raetz, C. R., Ellsworth, K. (1992) Identification and selective inhibition of an isozyme of steroid 5α-reductase in human scalp. Proc. Natl. Acad. Sci. USA 89 , 10787–10791.
Ellsworth K. , 'Identification and selective inhibition of an isozyme of steroid 5α-reductase in human scalp ' (1992 ) 89 Proc. Natl. Acad. Sci. USA : 10787 -10791 .
Hoffmann, R., Happle, R. (2000) Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment. Eur. J. Dermatol. 10 , 410–417.
Happle R. , 'Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment ' (2000 ) 10 Eur. J. Dermatol. : 410 -417 .
Issa, S., Schnabel, D., Feix, M., Wolf, L., Schaefer, H. E., Russell, D. W., Schweikert, H. U. (2002) Human osteoblast-like cells express predominantly steroid 5α-reductase type 1. J. Clin. Endocrinol. Metab. 87 , 5401–5407.
Schweikert H. U. , 'Human osteoblast-like cells express predominantly steroid 5α-reductase type 1 ' (2002 ) 87 J. Clin. Endocrinol. Metab. : 5401 -5407 .
Jarman, M., Smith, H. J., Nicholls, P. J., Simons, C. (1998) Inhibitors of enzymes of androgen biosynthesis: cytochrome P450 17α and 5α-steroid reductase. Nat. Prod. Rep. 15 , 495–512.
Simons C. , 'Inhibitors of enzymes of androgen biosynthesis: cytochrome P45017α and 5α-steroid reductase ' (1998 ) 15 Nat. Prod. Rep. : 495 -512 .
Kenny, B., Ballard, S., Blagg, J., Fox, D. (1997) Pharmacological options in the treatment of benign prostatic hyperplasia. J. Med. Chem. 40 , 1293–1315.
Fox D. , 'Pharmacological options in the treatment of benign prostatic hyperplasia ' (1997 ) 40 J. Med. Chem. : 1293 -1315 .
Li, X., Singh, S. M., Labrie, F. (1995) Synthesis and in vitro activity of 17β-(N-alkyl/arylformamido)- and 17βbeta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5α-androstan-3-ones as inhibitors of human 5α-reductases and antagonists of the androgen receptor. J. Med. Chem. 38 , 1158–1173.
Labrie F. , 'Synthesis and in vitro activity of 17β-(N-alkyl/arylformamido)- and 17βbeta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5α-androstan-3-ones as inhibitors of human 5α-reductases and antagonists of the androgen receptor ' (1995 ) 38 J. Med. Chem. : 1158 -1173 .
Machetti, F., Guarna, A. (2002) Novel inhibitors of 5α-reductase. Expert. Opin. Ther. Patents 12 , 201–215.
Guarna A. , 'Novel inhibitors of 5α-reductase ' (2002 ) 12 Expert. Opin. Ther. Patents : 201 -215 .
Melcangi, R. C., Poletti, A., Cavarretta, I., Celotti, F., Colciago, A., Magnaghi, V., Motta, M., Negri-Cesi, P., Martini, L. (1998) The 5alpha-reductase in the central nervous system: expression and modes of control. J. Steroid Biochem. Mol. Biol. 65 , 295–299.
Martini L. , 'The 5alpha-reductase in the central nervous system: expression and modes of control ' (1998 ) 65 J. Steroid Biochem. Mol. Biol. : 295 -299 .
Münster, U., Hammer, S., Blume-Peytavi, U., Schäfer-Korting, M. (2003) Testosterone metabolism in human skin cells in vitro and its interaction with estradiol and dutasteride. Skin. Pharmacol. Appl. Skin. Physiol. 16 , 356–366.
Schäfer-Korting M. , 'Testosterone metabolism in human skin cells in vitro and its interaction with estradiol and dutasteride ' (2003 ) 16 Skin. Pharmacol. Appl. Skin. Physiol. : 356 -366 .
Normington, K., Russel, D. W. (1992) Tissue distribution and kinetic characterisation of rat steroid 5α-reductase isoenzymes. J. Biol. Chem. 267 , 19548–19554.
Russel D. W. , 'Tissue distribution and kinetic characterisation of rat steroid 5α-reductase isoenzymes ' (1992 ) 267 J. Biol. Chem. : 19548 -19554 .
Occhiato, E. G., Guarna, A., Danza, G., Serio, M. (2004) Selective non-steroidal inhibitors of 5α-reductase type 1. J. Steroid Biochem. Mol. Biol. 88 , 1–16.
Serio M. , 'Selective non-steroidal inhibitors of 5α-reductase type 1 ' (2004 ) 88 J. Steroid Biochem. Mol. Biol. : 1 -16 .
Ondré, D., Wölfling, J., Tóth, I., Szécsi, M., Julesz, J., Schneider, Gy. (2009) Stereoselective synthesis of some steroidal 2-oxazolines, as novel potential inhibitors of 17α-hydroxylase-C 17,20 -lyase. Steroids 74 , 1025–1032.
Schneider Gy. , 'Stereoselective synthesis of some steroidal 2-oxazolines, as novel potential inhibitors of 17α-hydroxylase-C17,20-lyase ' (2009 ) 74 Steroids : 1025 -1032 .
Robaire, B., Henderson, N. A. (2006) Actions of 5α-reductase inhibitors on the epididymis. Mol. Cell. Endocrinol. 250 , 190–195.
Henderson N. A. , 'Actions of 5α-reductase inhibitors on the epididymis ' (2006 ) 250 Mol. Cell. Endocrinol. : 190 -195 .
Russel, D. W., Wilson, J. D. (1994) Steroid 5α-reductase: two genes/two enzymes. Ann. Rev. Biochem. 63 , 25–61.
Wilson J. D. , 'Steroid 5α-reductase: two genes/two enzymes ' (1994 ) 63 Ann. Rev. Biochem. : 25 -61 .
Salem, O. I., Frotscher, M., Scherer, C., Neugebauer, A., Biemel, K., Streiber, M., Maas, R., Hartmann, R. W. (2006) Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids. J. Med. Chem. 49 , 748–759.
Hartmann R. W. , 'Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids ' (2006 ) 49 J. Med. Chem. : 748 -759 .
Steers, W. D. (2001) 5α-reductase activity in the prostate. Urology 58 , 17–24.
Steers W. D. , '5α-reductase activity in the prostate ' (2001 ) 58 Urology : 17 -24 .
Sun, Z. Y, Xie, H., Tu, Z. H. (1999) Effect of Finasteride and Epristeride on steroid 5α-reductase kinetics — a comparative in vitro study. Ind. J. Pharmacol. 31 , 120–123.
Tu Z. H. , 'Effect of Finasteride and Epristeride on steroid 5α-reductase kinetics — a comparative in vitro study ' (1999 ) 31 Ind. J. Pharmacol. : 120 -123 .
Sun, Z. Y., Zheng, W. J., Feng, J., Tu, Z. H. (1998) A convenient and rapid method to study enzymatic kinetics of steroid 5α-reductase inhibitors. Ind. J. Pharmacol. 30 , 257–282.
Tu Z. H. , 'A convenient and rapid method to study enzymatic kinetics of steroid 5α-reductase inhibitors ' (1998 ) 30 Ind. J. Pharmacol. : 257 -282 .
Thigpen, A. E., Russell, D. W. (1992) Four-amino acid segment in steroid 5α-reductase 1 confers sensitivity to finasteride, a competitive inhibitor. J. Biol. Chem. 267 , 8577–8583.
Russell D. W. , 'Four-amino acid segment in steroid 5α-reductase 1 confers sensitivity to finasteride, a competitive inhibitor ' (1992 ) 267 J. Biol. Chem. : 8577 -8583 .
Thigpen, A. E., Silver, R. I., Guileyardo, J. M., Casey, M. L., McConnell, J. D., Russell, D. W. (1993) Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J. Clin. Invest. 92 , 903–910.
Russell D. W. , 'Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression ' (1993 ) 92 J. Clin. Invest. : 903 -910 .
Tian, G., Haffner, C. D. (2001) Linear relationship between the ligand binding energy and the activation energy of time-dependent inhibition of steroid 5α-reductase by 1–4-azasteroids. J. Biol. Chem. 276 , 21359–21364.
Haffner C. D. , 'Linear relationship between the ligand binding energy and the activation energy of time-dependent inhibition of steroid 5α-reductase by 1–4-azasteroids ' (2001 ) 276 J. Biol. Chem. : 21359 -21364 .
Titus, M. A., Gregory, C. W., Ford, O. H. 3 rd , Schell, M. J., Maygarden, S. J., Mohler, J. L. (2005) Steroid 5α-reductase isozymes I and II in recurrent prostate cancer. Clin. Cancer. Res. 11 , 4365–4371.
Mohler J. L. , 'Steroid 5α-reductase isozymes I and II in recurrent prostate cancer ' (2005 ) 11 Clin. Cancer. Res. : 4365 -4371 .
Torres, J. M., Ortega, E. (2003) Precise quantitation of 5α-reductase type 1 mRNA by RT-PCR in rat liver and its positive regulation by testosterone and dihydrotestosterone. Biochem. Biophys. Res. Commun. 308 , 469–473.
Ortega E. , 'Precise quantitation of 5α-reductase type 1 mRNA by RT-PCR in rat liver and its positive regulation by testosterone and dihydrotestosterone ' (2003 ) 308 Biochem. Biophys. Res. Commun. : 469 -473 .
Torres, J. M., Ortega, E. (2004) Precise quantitation of steroid 5α-reductase type 1 mRNA levels by RT-PCR in female rat liver. Endocr. Res. 30 , 149–157.
Ortega E. , 'Precise quantitation of steroid 5α-reductase type 1 mRNA levels by RT-PCR in female rat liver ' (2004 ) 30 Endocr. Res. : 149 -157 .
Zhu, Y. S., Imperato-McGinley, J. L. (2009) 5α-reductase isozymes and androgen actions in the prostate. Ann. N. Y. Acad. Sci. 1155 , 43–56.
Imperato-McGinley J. L. , '5α-reductase isozymes and androgen actions in the prostate ' (2009 ) 1155 Ann. N. Y. Acad. Sci. : 43 -56 .